Mevcut:*
Library | Materyal Türü | Barkod | Yer Numarası | Durum |
|---|---|---|---|---|
Searching... Pamukkale Merkez Kütüphanesi | Kitap | 0060618 | QP531.C663 2006 | Searching... Unknown |
Bound With These Titles
On Order
Özet
Özet
Destined to set the standard, this book meets the need for a didactic textbook focusing on the role of model systems in bioinorganic chemistry. The first part features concepts in bioinorganic chemistry such as electron transfer, medicinal inorganic chemistry, bioorganometallics and metal DNA complexes, while the second part presents inorganic model chemistry on metallo-enzymes, organized by metal ion.
Experts in the pertinent fields provide a didactically well-organized background on relevant biological systems, as well as on their structural, functional and spectroscopic properties. All chapters are similarly structured, each one beginning with a timeline featuring the most important historical facts on the subject, followed by a table of the most significant enzymes. The authors also summarize key developments and open questions within the respective model systems.
This book is aimed at senior undergraduate and graduate students in chemistry, biochemistry, life science and related fields.
Author Notes
Heinz-Bernhard Kraatz obtained his Ph.D. from the University of Calgary in 1993 (inorganic chemistry, with P. M. Boorman). After a shorter stay at the University of Maryland, he spent two years at the Weizmann Institute as a Minerva postdoctoral fellow (1994-1995). He was a Research associate at the National Research Council of Canada (1996-1997). In 1998 he was appointed to the University of Saskatchewan, where he was Associate Professor since 2001 and became full Professor in 2006. HBK is the Canada Reseach Chair in Biomaterials. He received several awards and was the organizer of meetings in bioinorganic chemistry and electrochemistry in Canada. Research in his group focusses on the design of peptides and surface-supported peptide assemblies modified by inorganic and organometallic moieties to study electron transfer and to develop new biosensors.
Nils Metzler-Nolte (ne Metzler) obtained his Ph.D. from the University of Munich in 1994 (Organoboron chemistry, with H. Noth). After a postdoctoral year with M. L. H. Green in Oxford, he started independent research at the Max-Planck-Institut fur Strahlenchemie (now MPI for Bioinorganic Chemistry). He obtained his Habilitation at the University of Bochum in May 2000 and was soonafter appointed Professor for bioinorganic chemistry at the University of Heidelberg. In 2006, he accepted a Chair for Inorganic Chemistry at the University of Bochum. His work has been recognized by several awards and he has organized national and international conferences in bioorganometallic chemistry. His research interest is in bioorganometallic chemistry and functional bioconjugates with transition metals, including aspects of medicinal inorganic chemistry.
Reviews (1)
Choice Review
Concepts and Models in Bioinorganic Chemistry is the latest in a small group of course resources centered around this emerging subfield of chemistry, one of only two published in the past ten years. Unlike its contemporary Bioinorganic Chemistry: A Short Course, by Rosette M. Roat-Malone (CH, May'03, 40-5232), Concepts and Models is designed for the more advanced student or researcher in this field. It is organized into 17 chapters, each of which treats a separate topic in bioinorganic chemistry. With the exception of the first chapter, each additional chapter functions as a review of the current state of knowledge for each subtopic. Individual chapters are written by separate authors or teams of coauthors, respected researchers in that specific subtopic. This book will be an essential resource for any graduate student or researcher in the field. Not appropriate for undergraduates. ^BSumming Up: Highly recommended. Graduate students through professionals. R. M. Granger II Sweet Briar College
Table of Contents
| Foreword | p. V |
| Preface | p. VII |
| List of Contributors | p. XIX |
| Abbreviations | p. XXIII |
| 1 The Biodistribution of Metal Ions | p. 1 |
| 1.1 Introduction | p. 2 |
| 1.2 Rates of Exchange | p. 5 |
| 1.3 The Limitations of Water as a Solvent | p. 5 |
| 1.4 Equilibrium: Values of Binding Constants | p. 7 |
| 1.5 Quantitative Metal Ion Equilibria: Donor Strength | p. 7 |
| 1.6 The Effect of Size and Charge of Metal Ions | p. 8 |
| 1.7 The Effect of Electron Affinity | p. 11 |
| 1.8 Control over Ligand Concentration | p. 14 |
| 1.9 The Compartments of Organisms | p. 16 |
| 1.10 Transport | p. 18 |
| 1.11 The Irreversible Binding of Fe, Co, Ni, Mg, and Mo (W) | p. 19 |
| 1.12 Vanadium, Molybdenum, and Tungsten | p. 20 |
| 1.13 Rates of Exchange | p. 21 |
| 1.14 Summary | p. 22 |
| References | p. 23 |
| 2 Medicinal Inorganic Chemistry | p. 25 |
| 2.1 Introduction | p. 26 |
| 2.2 Key Developments | p. 27 |
| 2.2.1 Therapeutic Agents | p. 27 |
| 2.2.1.1 Arsphenamine: The First Comprehensive Structure-Activity Relationship | p. 28 |
| 2.2.1.2 Lithium in Psychiatry: The Dose-Response Relationship | p. 29 |
| 2.2.1.3 Cisplatin: Targeted Toxicity | p. 31 |
| 2.2.1.4 The Discovery of Essential Trace Elements | p. 32 |
| 2.2.1.5 Treatment of Copper- and Iron-Overload Disorders: Metal Ions as Targets | p. 33 |
| 2.2.1.6 Radiopharmaceuticals: Utilizing the Nuclear Properties of Metal Ions | p. 34 |
| 2.2.2 Diagnostic Agents | p. 35 |
| 2.2.2.1 [superscript 99m] Tc-Labeled Diagnostic Agents | p. 36 |
| 2.2.2.2 Targeted Myocardial Imaging with [superscript 99m] Tc-Sestamibi | p. 36 |
| 2.2.2.3 [superscript 67]Ga-Citrate Scintigraphy: Computed Tomography | p. 37 |
| 2.2.2.4 [superscript 111]In-DTPA-Octreotide-Peptide Binding for Improved Tissue Targeting | p. 37 |
| 2.2.2.5 Gadolinium-based MRI Contrast Enhancement | p. 38 |
| 2.3 Summary of Key Concepts | p. 39 |
| 2.4 Selected Current Research Directions | p. 39 |
| 2.4.1 Therapeutic Agents | p. 39 |
| 2.4.1.1 Vanadyl Insulin Mimetic Agents: Anticipating Biomolecular Interaction | p. 39 |
| 2.4.1.2 Multifunctional Antimalarial Metallopharmaceuticals | p. 40 |
| 2.4.1.3 Using Oxidation State to Advantage: Pt(IV) Compounds | p. 41 |
| 2.4.2 Diagnostic Agents | p. 41 |
| 2.5 Open Questions | p. 42 |
| References | p. 44 |
| 3 The Chemical Toxicology of Metals and Metalloids | p. 47 |
| 3.1 Introduction | p. 48 |
| 3.2 Arsenic | p. 48 |
| 3.2.1 Dietary Sources of Arsenic | p. 51 |
| 3.2.2 Arsenic-Selenium Antagonism: Two Wrongs That Do Make a Right! | p. 52 |
| 3.3 Mercury | p. 52 |
| 3.3.1 Mercury in Food | p. 55 |
| 3.3.2 Mercury-Selenium Antagonism and Synergism | p. 56 |
| 3.3.3 Mercury Chelation Therapy | p. 57 |
| 3.4 Chromium | p. 58 |
| 3.5 The Promise of New Techniques | p. 58 |
| References | p. 59 |
| 4 Theoretical Modeling of Redox Processes in Enzymes and Biomimetic Systems | p. 63 |
| 4.1 Introduction | p. 64 |
| 4.2 Computational Model | p. 66 |
| 4.3 Nonheme Iron Active Sites That Perform Alkane Hydroxylation and Olefin Oxidation | p. 68 |
| 4.4 Keto Acid-Dependent Dioxygenases and Their Synthetic Analogues | p. 72 |
| 4.5 Copper Complexes in Enzymes and Synthetic Systems | p. 76 |
| 4.5.1 Enzymes with Copper Dimer Complexes | p. 76 |
| 4.5.2 Enzymes with Copper Monomer Complexes | p. 80 |
| 4.6 Manganese Complexes That Oxidize Water to Dioxygen | p. 81 |
| 4.6.1 The Electronic Structure of the Highly Oxidized State | p. 84 |
| 4.6.2 The O-O Bond-Formation Reaction | p. 86 |
| 4.7 Conclusions | p. 88 |
| References | p. 88 |
| 5 Charge Transport in Biological Molecules | p. 93 |
| 5.1 Introduction | p. 94 |
| 5.1.1 A Brief History of Biological Electron Transfer | p. 95 |
| 5.1.2 Theoretical Considerations | p. 96 |
| 5.2 Electron Transfer in Proteins | p. 98 |
| 5.2.1 Studies Involving Metal-labeled Proteins | p. 99 |
| 5.2.1.1 Redox Properties | p. 100 |
| 5.2.1.2 Studies Involving Azurin | p. 100 |
| 5.3 Electron Transfer in Peptides | p. 103 |
| 5.4 Charge Transfer in DNA | p. 107 |
| 5.4.1 Fundamental Properties | p. 107 |
| 5.4.2 Molecular Diagnostics | p. 107 |
| 5.4.2.1 Sequence Detection | p. 107 |
| 5.4.2.2 Protein-DNA Interactions | p. 109 |
| 5.5 Summary and Open Questions | p. 110 |
| References | p. 111 |
| 6 Bioorganometallic Chemistry | p. 113 |
| 6.1 Introduction | p. 115 |
| 6.2 Organometallic Complexes in Nature | p. 116 |
| 6.3 Synthetic Organometallic Complexes with Bioligands | p. 119 |
| 6.4 Organometallic Pharmaceuticals | p. 123 |
| 6.5 Analytical Bioorganometallic Chemistry | p. 125 |
| 6.6 Bioorganometallic Catalysis | p. 130 |
| 6.7 Conclusions and Outlook | p. 133 |
| References | p. 134 |
| 7 The Bioinorganic Side of Nucleic Acid Chemistry: Interactions with Metal Ions | p. 137 |
| 7.1 Introduction: Nucleic Acids and Metals | p. 138 |
| 7.2 Modeling Metal-Nucleic Acid Interactions | p. 142 |
| 7.2.1 Selected "Classical" Aspects | p. 142 |
| 7.2.1.1 Metal-Binding Patterns | p. 142 |
| 7.2.1.2 Metals at Close Distance | p. 144 |
| 7.2.1.3 DNA Distortion by GG Adduct | p. 146 |
| 7.2.1.4 Pt Binding and NMR | p. 147 |
| 7.2.1.5 Subtle Consequences of Metal Coordination | p. 148 |
| 7.2.1.5.1 Effect of Metal Coordination on H Bonding | p. 148 |
| 7.2.1.5.2 Nucleobase Acidification | p. 148 |
| 7.2.1.5.3 Metals and Nucleobase Tautomerism | p. 149 |
| 7.2.1.6 Irreversible Nucleobase Modifications | p. 150 |
| 7.2.2 More Recent Developments | p. 151 |
| 7.2.2.1 Molecular Squares | p. 151 |
| 7.2.2.2 M-DNA | p. 152 |
| 7.2.2.3 Metal-Containing Antisense and Antigene Reagents | p. 153 |
| 7.2.2.4 Others | p. 154 |
| 7.3 Take-Home Message | p. 154 |
| 7.4 Open Questions and Perspectives | p. 155 |
| References | p. 156 |
| 8 Nuclease and Peptidase Models | p. 159 |
| 8.1 Introduction | p. 159 |
| 8.2 Mechanistic Considerations | p. 161 |
| 8.3 Substrates for Model Studies | p. 163 |
| 8.4 Peptidase Models | p. 166 |
| 8.5 Nuclease Models | p. 167 |
| 8.5.1 Simple Mononuclear Metal Complexes | p. 167 |
| 8.5.2 Dinuclear Metal Complexes | p. 168 |
| 8.5.3 Metal-Functional Group Cooperation | p. 170 |
| 8.6 Applications | p. 172 |
| References | p. 173 |
| 9 Metalloporphyrins, Metalloporphyrinoids, and Model Systems | p. 177 |
| 9.1 Introduction: Biological Background | p. 278 |
| 9.2 Model Systems and Model Compounds to Understand Biological Function | p. 182 |
| 9.2.1 Iron Porphyrins: Hemes in Biological Electron Transfer, Oxygen Transport and Activation | p. 188 |
| 9.2.1.1 Heme Proteins in Electron Transfer | p. 188 |
| 9.2.1.2 Heme Proteins in the Transport and Activation of Small Molecules | p. 189 |
| 9.2.2 Nickel Porphinoids: Coenzyme F430 in Biological Methane Formation | p. 193 |
| 9.2.2.1 The Redox Chemistry of Coenzyme F430 and its Derivatives | p. 194 |
| 9.2.2.2 Structure-Reactivity Relationships for Nickel Porphinoids | p. 195 |
| 9.2.2.3 Probing the Reactivity of Ni(I)F430M | p. 197 |
| 9.2.2.4 Synthetic Complexes as Models for Coenzyme F430 | p. 199 |
| 9.2.3 Cobalt Corrinoids: Biological Organometallic Transformations | p. 199 |
| 9.2.4 Organometallic B[subscript 12] Derivatives and their Organometallic Reactivities | p. 204 |
| 9.3 Summary of Key Concepts | p. 207 |
| 9.4 Open Questions and the Direction of Future Research | p. 209 |
| References | p. 209 |
| 10 Model Complexes for Vanadium-Containing Enzymes | p. 213 |
| 10.1 Biological Background and Motivation | p. 214 |
| 10.1.1 General Aspects of Vanadium Chemistry Related to Biological Functions | p. 214 |
| 10.1.2 Vanadium-Dependent Enzymes | p. 216 |
| 10.1.2.1 Haloperoxidases and Vanadate in Phosphoryl Transfer Enzymes | p. 216 |
| 10.1.2.2 Vanadium-Nitrogenase | p. 221 |
| 10.2 Model Compounds | p. 222 |
| 10.2.1 Models of Vanadate-Dependent Haloperoxidases | p. 222 |
| 10.2.2 Models of Vanadium-Nitrogenase | p. 227 |
| 10.3 Summary of Key Concepts | p. 229 |
| 10.4 Open Questions and the Direction of Future Research | p. 230 |
| References | p. 232 |
| 11 Model Complexes for Molybdenum- and Tungsten-Containing Enzymes | p. 237 |
| 11.1 Biological Background and Motivation | p. 238 |
| 11.1.1 Introduction | p. 238 |
| 11.1.2 Enzyme Active Sites | p. 239 |
| 11.1.2.1 Structure | p. 239 |
| 11.1.2.2 Spectroscopy | p. 240 |
| 11.1.2.3 Reactivity | p. 241 |
| 11.1.3 Questions to be Answered by Model Compounds | p. 243 |
| 11.2 Model Compounds | p. 244 |
| 11.2.1 Background | p. 244 |
| 11.2.2 Stabilization of Mononuclear Oxo-Molybdenum Centers | p. 244 |
| 11.2.3 Electronic Contributions of Thiolate Ligands | p. 247 |
| 11.2.4 Towards Accurate Structural Models | p. 249 |
| 11.2.5 Reactivity and Spectroscopic Studies of {{MoS[subscript 4]}} Centers | p. 250 |
| 11.2.6 Computational Models of the XO Family | p. 251 |
| 11.3 Summary | p. 251 |
| 11.4 Open Questions | p. 252 |
| References | p. 255 |
| 12 Structural and Functional Models for Oxygen-Activating Nonheme Iron Enzymes | p. 259 |
| 12.1 Biological Background and Motivation | p. 260 |
| 12.2 Dinuclear Iron Centers | p. 263 |
| 12.3 Diiron Models | p. 266 |
| 12.3.1 Structural Models | p. 266 |
| 12.3.2 Reactivity with O[subscript 2] | p. 268 |
| 12.3.3 Oxodiiron Intermediates | p. 270 |
| 12.4 Monoiron Active Sites with a 2-His-1-Carboxylate Facial Triad Motif | p. 272 |
| 12.4.1 [alpha]-Keto-acid-Dependent Enzymes | p. 272 |
| 12.4.2 Rieske Dioxygenases | p. 274 |
| 12.5 Monoiron Models | p. 275 |
| 12.5.1 Functional Models | p. 275 |
| 12.5.1.1 [alpha]KA-Dependent Enzymes | p. 275 |
| 12.5.1.2 Rieske Dioxygenases | p. 277 |
| 12.5.2 Oxoiron(IV) Intermediates | p. 280 |
| 12.6 Summary of Key Concepts | p. 282 |
| 12.7 Open Questions and the Direction of Future Research | p. 283 |
| References | p. 283 |
| 13 Model Chemistry of the Iron-Sulfur Protein Active Sites | p. 287 |
| 13.1 Introduction | p. 288 |
| 13.2 Basic Iron and Sulfur Chemistry | p. 290 |
| 13.3 Common Iron-Sulfur Geometries | p. 290 |
| 13.4 Required Protein and Peptide Coordination Environments | p. 294 |
| 13.5 Syntheses of Model Compounds | p. 294 |
| 13.5.1 Mononuclear Rubredoxin Models [Fe-4S] | p. 294 |
| 13.5.2 Binuclear Ferredoxin Models [2Fe-2S] | p. 295 |
| 13.5.3 Trinuclear Analogues [3Fe-4S] | p. 296 |
| 13.5.3.1 Linear Analogues [3Fe-4S] | p. 296 |
| 13.5.3.2 Cubane-Derived Analogues [3Fe-4S] | p. 296 |
| 13.5.3.3 Tetranuclear Cubane Analogues [4Fe-4S] | p. 297 |
| 13.5.4 Non-Homoleptic Clusters [4Fe-4S] | p. 298 |
| 13.5.5 Models of Nitrogenase Clusters | p. 298 |
| 13.5.5.1 FeMoco Analogues | p. 300 |
| 13.5.5.2 P-Cluster Analogues | p. 301 |
| 13.6 Properties of Analogues and Their Relation to Protein-Bound Clusters | p. 302 |
| 13.6.1 Electrochemistry of Model Compounds | p. 303 |
| 13.6.2 Oxidation States and Mossbauer Studies | p. 303 |
| References | p. 304 |
| 13.7 Conclusions | p. 304 |
| 14 Model Complexes of Ni-Containing Enzymes | p. 309 |
| 14.1 Introduction | p. 310 |
| 14.2 Urease | p. 310 |
| 14.2.1 The Enzyme | p. 310 |
| 14.2.2 Models | p. 312 |
| 14.3 NiFe Hydrogenase | p. 316 |
| 14.3.1 The Enzyme | p. 316 |
| 14.3.2 Models | p. 318 |
| 14.4 Carbon Monoxide Dehydrogenase/Acetyl Coenzyme A Synthase (CODH/ACS) | p. 320 |
| 14.4.1 The Enzyme | p. 320 |
| 14.4.2 Models | p. 322 |
| 14.5 Conclusions | p. 326 |
| References | p. 327 |
| 15 Hydrogenases and Model Complexes | p. 331 |
| 15.1 Introduction | p. 332 |
| 15.2 What are Hydrogenases? | p. 332 |
| 15.3 Nickel-Iron (NiFe-Hase) and Nickel-Iron-Selenium (NiFeSe-Hase) Hydrogenases | p. 335 |
| 15.4 Iron-Iron Hydrogenases | p. 338 |
| 15.5 Similarities and Differences between NiFe-Hase and FeFe-Hase | p. 341 |
| 15.6 Synthetic Complexes that Model Hydrogenases | p. 342 |
| 15.6.1 Models of NiFe-Hase Active-Sites | p. 343 |
| 15.6.1.1 Ni Chemistry | p. 343 |
| 15.6.1.2 Hydride and Dihydrogen Chemistry and Electrocatalysis | p. 347 |
| 15.6.1.3 Iron Cyanide, Carbonyl Chemistry | p. 349 |
| 15.6.1.4 NiFe Bimetallic Model Complexes | p. 352 |
| 15.6.2 FeFe-Hase Models | p. 353 |
| 15.7 Conclusions | p. 358 |
| 15.8 Open Questions and the Direction of Future Research | p. 358 |
| References | p. 359 |
| 16 Model Complexes for Copper-Containing Enzymes | p. 363 |
| 16.1 Introduction | p. 364 |
| 16.2 Biological Background: Copper Proteins and Motivation for Biomimetic Studies | p. 365 |
| 16.2.1 Copper Ion Properties and Biological Ligands | p. 365 |
| 16.2.2 Electron-Transfer Proteins | p. 368 |
| 16.2.2.1 Blue Copper Proteins | p. 368 |
| 16.2.2.2 Purple Cu[subscript A] Centers | p. 369 |
| 16.2.3 Dioxygen-Processing Proteins | p. 369 |
| 16.2.3.1 Dicopper Sites in Hemocyanin (Hc), Tyrosinase and CO | p. 370 |
| 16.2.3.2 Other Oxygenases | p. 371 |
| 16.2.3.3 Oxidases | p. 373 |
| 16.3 Model Compounds | p. 377 |
| 16.3.1 The Synthetic Model Approach for Copper and Cu[superscript 1]/O[subscript 2] Chemistry | p. 377 |
| 16.3.2 Dicopper O[subscript 2] Chemistry; Models for Cu[subscript 2]O[subscript 2] Proteins | p. 379 |
| 16.3.2.1 Side-on Peroxo Core | p. 379 |
| 16.3.2.2 End-on Peroxo Core | p. 380 |
| 16.3.2.3 Bis([mu]-oxo) Core | p. 381 |
| 16.3.2.4 Model for Tyrosinase; Aromatic Hydroxylation | p. 382 |
| 16.3.3 Galactose Oxidase Models | p. 383 |
| 16.3.4 CcO Modeling: Heme-Copper Dioxygen Complexes | p. 385 |
| 16.3.5 Blue Copper Type 1 (T1) Models | p. 387 |
| 16.4 Summary of Key Concepts | p. 388 |
| 16.5 Open Questions and Directions for Future Research | p. 389 |
| 16.5.1 Copper-Dioxygen Chemistry | p. 389 |
| 16.5.2 Models for Active-Site Crosslinked Amino-Acid Residues | p. 390 |
| 16.5.3 Cytochrome c Oxidase Models | p. 390 |
| 16.5.4 Blue (T1) and Purple (Cu[subscript A]) Models | p. 390 |
| References | p. 391 |
| 17 Model Complexes for Zinc-Containing Enzymes | p. 397 |
| 17.1 Introduction | p. 398 |
| 17.1.1 Coordination Motifs | p. 398 |
| 17.1.2 Ligand Geometries | p. 399 |
| 17.1.3 Classification of Mononuclear Zinc Peptidases | p. 403 |
| 17.2 Mononuclear Zinc Enzymes and Models | p. 405 |
| 17.2.1 Zinc Enzymes with a [His[subscript 3]] Motif and Their Model Complexes | p. 405 |
| 17.2.1.1 Metzincins | p. 405 |
| 17.2.1.2 Carbonic Anhydrase | p. 406 |
| 17.2.1.3 Zinc Complexes with Hydridotris(pyrazol-1-yl)borate | p. (Tp) Ligands |
| 17.2.1.4 Zinc Complexes with Neutral N,N,N Ligands | p. 410 |
| 17.2.2 Zinc Enzymes with a 2-His-1-Carboxylate Motif and Their Models | p. 410 |
| 17.2.2.1 Gluzincins and Aspzincins | p. 412 |
| 17.2.2.2 Carboxypeptidases | p. 413 |
| 17.2.2.3 Zinc Complexes with N,N,O Ligands | p. 414 |
| 17.2.3 Liver Alcohol Dehydrogenase and Models | p. 417 |
| 17.2.4 5-Aminolevulinic Acid Dehydratase and Adenosine Deaminase DNA Repair Protein | p. 420 |
| 17.3 Dinuclear Zinc Enzymes and Models | p. 422 |
| 17.3.1 Metallo[Beta]-Lactamases | p. 423 |
| 17.3.2 Aminopeptidases | p. 425 |
| 17.3.3 Alkaline Phosphatases and Purple Acid Phosphatase | p. 426 |
| 17.4 Conclusions | p. 429 |
| References | p. 429 |
| Subject Index | p. 433 |
